Exploring the language used to describe older patients at multidisciplinary cancer conferences

Older adults with cancer often present with distinct complexities that complicate their care, yet the language used to discuss their management at multidisciplinary cancer conferences (MCCs) remains poorly understood. A mixed methods study was conducted at a tertiary cancer centre in Toronto, Canada...

Descripción completa

Detalles Bibliográficos
Autores: Kim, Valerie S., Carrozzi, Anthony, Papadopoulos, Efthymios, Tejero, Isabel, Thiruparanathan, Thirisangi, Perlis, Nathan, Hope, Andrew J., Jang, Raymond W., Alibhai, Shabbir
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/69906
Acceso en línea:http://hdl.handle.net/10230/69906
http://dx.doi.org/10.3390/cancers16081477
Access Level:acceso abierto
Palabra clave:Communicate
Frailty
Geriatric assessment
Geriatric oncology
Language
Multidisciplinary cancer conferences
Tumour boards
Descripción
Sumario:Older adults with cancer often present with distinct complexities that complicate their care, yet the language used to discuss their management at multidisciplinary cancer conferences (MCCs) remains poorly understood. A mixed methods study was conducted at a tertiary cancer centre in Toronto, Canada, where MCCs spanning five tumour sites were attended over six months. For presentations pertaining to a patient aged 75 or older, a standardized data collection form was used to record their demographic, cancer-related, and non-cancer-related information, as well as the presenter's specialty and training level. Descriptive statistics and thematic analysis were employed to explore MCC depictions of older patients (n = 75). Frailty status was explicitly mentioned in 20.0% of presentations, but discussions more frequently referenced comorbidity burden (50.7%), age (33.3%), and projected treatment tolerance (30.7%) as surrogate measures. None of the presentations included mentions of formal geriatric assessment (GA) or validated frailty tools; instead, presenters tended to feature select GA domains and subjective descriptions of appearance ("looks to be fit") or overall health ("relatively healthy"). In general, MCCs appeared to rely on age-focused language that may perpetuate ageism. Further work is needed to investigate how frailty and geriatric considerations can be objectively incorporated into discussions in geriatric oncology.